Alzheimer's Press Release Heard ‘round the World
In a press release last week with perhaps the longest headline in history, Eisai Co., Ltd., a Japanese firm, and Biogen Inc., the Cambridge company behind last year’s ill-fated launch of the Alzheimer’s drug, Aduhelm, announced dramatic results from a clinical trial of a new Alzheimer’s medication called lecanemab.
Medical experts cautioned against readi…
Keep reading with a 7-day free trial
Subscribe to Aging in America to keep reading this post and get 7 days of free access to the full post archives.